Short
Pain medicine that is going to hurt
Ktov has blown up over 113% in the last several days. While its hard to do technical analysis on a stock that is sub a dollar, Im going to make it anyways for a friend.
Given the past trends after massive spikes, I would expect the slight downtrend to last another day.
The massive buying volumes coming in over the past 2 days also indicate that people are being sold into heavily.
I believe the boat has been missed if you wanted to get rich off of this stock. All bios are hot right now and it would only make sense that a company who is dealing in the single digit millions of funding is not going anywhere fast.
I believe there is strong correlation between the IPO that happened a month ago where 20MM shares were offered at $0.30 a share.
If people really believed this was going to be huge, they would have bought the stock back in may 2018 when the drug was first approved by the FDA.
barrons.com/press-release/kitov-closes-6-0-million-public-offering-01584446766?tesla=y&tesla=y
seekingalpha.com/news/3576290-kitov-launches-consensi-in-u-s
Nothing more than a pump and dump
Given the past trends after massive spikes, I would expect the slight downtrend to last another day.
The massive buying volumes coming in over the past 2 days also indicate that people are being sold into heavily.
I believe the boat has been missed if you wanted to get rich off of this stock. All bios are hot right now and it would only make sense that a company who is dealing in the single digit millions of funding is not going anywhere fast.
I believe there is strong correlation between the IPO that happened a month ago where 20MM shares were offered at $0.30 a share.
If people really believed this was going to be huge, they would have bought the stock back in may 2018 when the drug was first approved by the FDA.
barrons.com/press-release/kitov-closes-6-0-million-public-offering-01584446766?tesla=y&tesla=y
seekingalpha.com/news/3576290-kitov-launches-consensi-in-u-s
Nothing more than a pump and dump
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.